Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Accumulated Depreciation & Amortization: 2013-2016

  • Tvardi Therapeutics' Accumulated Depreciation & Amortization rose 15.22% to $8.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $26.7 million, marking a year-over-year change of. This contributed to the annual value of $8.1 million for FY2016, which is 15.22% up from last year.
  • Tvardi Therapeutics' Accumulated Depreciation & Amortization amounted to $8.1 million in Q4 2016, which was up 15.22% from $7.0 million recorded in Q4 2015.
  • In the past 5 years, Tvardi Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $8.1 million in Q4 2016 and a low of $5.4 million during Q4 2013.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $7.0 million (2015), whereas its average is $7.1 million.
  • Data for Tvardi Therapeutics' Accumulated Depreciation & Amortization shows a peak YoY grew of 15.22% (in 2016) over the last 5 years.
  • Quarterly analysis of 4 years shows Tvardi Therapeutics' Accumulated Depreciation & Amortization stood at $5.4 million in 2013, then grew by 14.35% to $6.2 million in 2014, then climbed by 13.32% to $7.0 million in 2015, then grew by 15.22% to $8.1 million in 2016.
  • Its last three reported values are $8.1 million in Q4 2016, $7.0 million for Q4 2015, and $6.2 million during Q4 2014.